Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 9, 2016
Medical Communications top ten

Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …

News
astrazeneca_plaque

AZ to terminate 700 US jobs

December 9, 2016
Manufacturing and Production, Medical Communications AstraZeneca, job cuts

AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …

News
china_pic

Top Pharmaceutical Markets 2016: China

December 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis

Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …

News
mice

Flickering LEDs could light the way for new Alzheimer’s treatment

December 8, 2016
Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice

Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …

News
abbvie_0

European thumbs up for Abbvie leukaemia drug

December 8, 2016
Medical Communications, Sales and Marketing AbbVie, Venclyxto

Abbvie has confirmed its Venclyxto (venetoclax) has been granted marketing authorisation by the European Commission (EC) as a monotherapy for …

News
novartis_window

Novartis’ drug doubly effective as chemotherapy for treating lung cancer

December 8, 2016
NSCLC, Novartis, chemotherapy

Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …

News
sicorbio

Teva embroiled in internal bribery investigation

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery

Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …

News

Mylan to restructure and slash around 10% of workforce

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …

News

BMS shares promising Opdivo/Yervoy data for advanced bladder cancer

December 8, 2016
Research and Development BMS, Yervoy, opdivo

BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …

News
shutterstock_212432119

New Alzheimer’s research edges closer to treatment & prevention

December 7, 2016
Research and Development Alzheimer's

A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …

News

AbbVie links up with Johns Hopkins University in cancer research

December 7, 2016
Medical Communications

AbbVie has announced that it has agreed a five-year collaboration agreement with Johns Hopkins University. The aim of the collaboration …

News
lisa_anson

AstraZeneca’s Lisa Anson appointed president of ABPI

December 7, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …

Appointment
imbruv_pack

Janssen reveals positive results from longest follow-up of Imbruvica

December 7, 2016
Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica

Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …

News
jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016
Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …

News

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016
Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …

News
astrazeneca_sign_sky

AZ lung cancer drug cuts disease progression by 70%

December 7, 2016
Research and Development AstraZeneca, Tagrisso

AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …

News
veeva_commercial_summit

Veeva releases key details from European Life Sciences Survey

December 6, 2016
veeva

Veeva, which held its European Life Sciences Summit last week, has announced some of the key findings from its European …

News
shire_image

Shire given permission for $400 million biologics manufacturing facility

December 6, 2016
Manufacturing and Production, Research and Development Co Meat, Ireland, Shire

Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …

News
jake_dupont

CMO of OncoMed Pharma resigns

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …

Appointment
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

Appointment
The Gateway to Local Adoption Series

Latest content

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026